67 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
. Moreover, Tenet’s business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
“treatment IND sales,” and “compassionate use sales,” shall not be construed as a First Commercial Sale.
[***] means [***]
“Fraud” means … , with respect to any Person, intentional common law fraud under Delaware Law in the making of one or more of the representations and warranties set forth
8-K
EX-99.4
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is required … , whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
in (A) a fraud or embezzlement against the Company or its affiliates or (B) an act of dishonesty against the Company or its affiliates that results
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy … of a Named Executive Officer for a felony under applicable law; (ii) the Named Executive Officer’s commission of or participation in (A) a fraud
PREM14A
7do4grp 7y
17 May 24
Preliminary proxy related to merger
4:36pm
DEFA14A
mq0j tmi6
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-10.5
vfjy7rd22i7dpqe7ln
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-2.1
hmy9dazobg
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am